Clinical Case Reports (Oct 2021)

Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy

  • Elisa Meucci,
  • Anna Radice,
  • Filippo Fassio,
  • Maria Loredana Chiara Iorno,
  • Donatella Macchia

DOI
https://doi.org/10.1002/ccr3.4935
Journal volume & issue
Vol. 9, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.

Keywords